Barclays Has Lowered Expectations for Elevance Health (NYSE:ELV) Stock Price
Elevance Health (NYSE:ELV – Get Free Report) had its price objective decreased by equities researchers at Barclays from $522.00 to $480.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 26.71% from the company’s current […]
Elevance Health (NYSE:ELV – Get Free Report) had its price objective decreased by equities researchers at Barclays from $522.00 to $480.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 26.71% from the company’s current […]
